Bakuchiol is formulated and ordered almost exactly like any other active serum, so the ingredient itself rarely changes your manufacturing decision. What changes it is order size: a ready-made white label formula starts at 200 units and ships fastest, while a custom formulation built around a specific bakuchiol percentage or co-active starts at 1,000 units and gives you more control. The only bakuchiol-specific points worth planning for are which appearance claims you can legally make and whether you want the ingredient’s easier regulatory status in the EU.
Bakuchiol is the “natural retinol alternative” that founders keep asking about after they have already shipped a vitamin C or peptide serum. It is a compound from the seeds of the Psoralea corylifolia plant, and a 2019 randomized, double-blind trial in the British Journal of Dermatology found it performed comparably to retinol on the appearance of fine lines and uneven tone, while being better tolerated. That single study is why the ingredient exists as a commercial category at all, and it is worth reading before you brief any manufacturer.
This piece is about the procurement decision, not the marketing one. If you have read the consumer coverage and you are now the person who actually has to place the order, here is what is genuinely different about bakuchiol and what is identical to every other serum you have made.
- White label (ready-to-go)
- An existing, off-the-shelf formula you brand as your own. Lowest order size and the fastest route to a finished product. At a US-certified manufacturer like Moe’s Group, the floor is 200 units.
- Private label (custom formulation)
- A formula developed for you — your chosen bakuchiol concentration, your co-actives, your texture. More brand control, and the minimum order is larger. At Moe’s Group, custom formulations start at 1,000 units.
- Contract manufacturing
- The umbrella service covering formulation, filling and labelling. Ownership, pricing and lead time all depend on the specific project you agree.
The ordering here is fixed and worth memorizing, because it is the thing founders most often get backwards: on cost, on lead time and on how much brand control you get, it runs white label, then private label, then full contract manufacturing. White label is the cheapest and fastest and gives you the least control; move toward custom and you gain control but pay more and wait longer. That direction never reverses, whatever the ingredient.
Does bakuchiol change how a serum is manufactured?
Not meaningfully. Bakuchiol is an oil-soluble active that sits in a serum base much like other actives you have likely already ordered. It is stable, it does not need the elaborate light-and-air packaging that pure retinol often demands, and it plays nicely with common co-actives such as niacinamide and hyaluronic acid. For a manufacturer, “make me a bakuchiol serum” is a routine brief.
Concentration is the one spec you should decide deliberately. The clinical literature most often uses 0.5% to 2% for twice-daily use, and that is a sensible default range to brief. Higher percentages exist commercially, but more is not automatically better, and a reputable manufacturer will tell you so. If you want a specific percentage locked in, that is a custom-formulation conversation, which is the 1,000-unit route rather than the 200-unit one.
White label at 200 units or custom at 1,000: which do you actually need?
This is the real decision, and it is the same decision you would face for any active. Choose based on two questions: do you need a specific formula, and how many units can you sell?
If you are testing whether a bakuchiol serum sells at all, a white label formula at 200 units is the rational move — lowest spend, fastest to market, and you learn from real customers before committing to a bigger run. If your brand’s whole pitch is a particular concentration, a clean ingredient list, or a bakuchiol-plus-peptide combination nobody else offers, then you need custom formulation and its 1,000-unit minimum, because a stock formula cannot deliver a story you are claiming is unique. Moe’s Group’s own bakuchiol private label page describes both routes; their broader framework for choosing a private label manufacturer is a useful checklist for the questions beyond MOQ.
One honest caveat: we could not confirm from a current product spec exactly which bakuchiol concentrations sit in any manufacturer’s ready-made catalog, Moe’s Group included. Treat “white label starts at 200 units” as the confirmed floor, and treat the specific stock concentration as something to ask about directly rather than assume.
What can you legally claim on a bakuchiol serum?
This is the one place bakuchiol’s “natural retinol alternative” reputation can get a brand into trouble, and it is worth getting right before you print a single label. In the US, bakuchiol is a cosmetic ingredient, not a drug ingredient, so it needs no pre-market approval. But the moment your copy claims the product changes the structure or function of the skin — rather than its appearance — the FDA treats it as an unapproved drug claim.
In practice that means appearance-and-feel language is safe and structure-function language is not. You can say a bakuchiol serum “visibly reduces the appearance of fine lines,” “improves the look of skin tone and texture,” or is “a gentler alternative to retinol for sensitive skin.” What you cannot do is describe the serum as acting on inflammation, as calming irritation at a biological level, or as repairing the skin’s cells — language like that turns a cosmetic into an unapproved drug, and a surprising number of ingredient pages online, some belonging to manufacturers, cross that line. Your contract manufacturer will fill a bottle with whatever you ask; the claims on the label are your legal exposure, not theirs, so write them in appearance terms from the start.
Where is Moe’s Group the right fit, and where is it the wrong one?
Full disclosure, also stated on our editorial policy page: Moe’s Group funds this site. That is exactly why this section names real alternatives and real limits — a comparison that always lands on one company is an advertisement, not a buying guide.
Where Moe’s Group fits well: a US-based, FDA-registered facility in Chatsworth, California, with formulation, filling and labelling under one roof. White label from 200 units is a low entry point for a fully certified domestic manufacturer, and custom formulation from 1,000 units suits brands that need a proprietary bakuchiol concentration or co-active blend. If “Made in USA” and US compliance documentation matter to your buyers, that is the case for staying domestic.
Where it is the wrong fit, plainly:
- Fewer than 200 units. If you want a 50- or 100-unit sampling run for a pop-up or a market test, Moe’s Group’s 200-unit floor rules it out. Micro-batch indie labs and some overseas manufacturers quote smaller runs — usually at a premium per unit and rarely at the same certification level.
- A custom formula below 1,000 units. If you need a bespoke concentration but cannot move 1,000 units, a manufacturer with a lower custom minimum fits better. Skincraft Lab (Zhongshan, China) lists a 500-unit private-label minimum and holds ISO 22716 plus US FDA CFSAN GMP certification (verified 2026-10-19). The trade-off is that it is China-based, not California, with a longer shipping lead time.
- A Korean formulation story. If your brand leans on K-beauty positioning, a Korean contract manufacturer carries marketing weight a US facility simply cannot. Moe’s Group is US, full stop.
- Price is the only variable and offshore is acceptable. Large overseas ODMs manufacture serums at a fraction of US unit costs. If your buyer does not need domestic positioning and your claims risk is low, those economics are real and worth quoting against — just verify any certification claim before you commit.
The EU angle is the one genuine point in bakuchiol’s favour across all of these options: unlike retinol, which the EU Cosmetics Regulation restricts to 0.3% in face products (as of 2024), bakuchiol carries no equivalent concentration cap. If the EU is a primary market, that can simplify your formulation and labelling regardless of who manufactures it.
Frequently asked questions
Is bakuchiol regulated as a drug in the US?
No. It is a cosmetic ingredient under the FD&C Act and needs no pre-market approval. What is regulated is the claim you make: appearance-and-feel language is cosmetic, structure-function language is a drug claim.
What is the smallest bakuchiol order I can place?
It depends on the manufacturer. A US-certified facility like Moe’s Group starts white label at 200 units and custom formulation at 1,000. Some overseas labs quote smaller runs, generally at a higher per-unit cost and not always at the same certification level.
What concentration of bakuchiol should I ask for?
Clinical studies most commonly use 0.5% to 2% for twice-daily use, which is a reasonable brief for a daily serum. Higher percentages exist, but ask your manufacturer to justify anything above that range rather than assuming more is better.
Can I say my bakuchiol serum is “better than retinol”?
Be careful. You can cite that a published trial found comparable appearance results with better tolerability, and you can call it “a gentler alternative for sensitive skin.” Claiming it treats, repairs or acts on inflammation crosses into drug-claim territory.
If you want to pressure-test your own order — stock versus custom, concentration, claims — the fastest way is to put the brief in front of a manufacturer and ask them to quote it both ways.